Veerhealth Care share news, announcements and annual reports
BSE: 511523Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹48.99.
30 Oct: open ₹49.48, high ₹49.48, low ₹48.00
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹97 Cr3,569th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 63.23
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹0.31 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 52.58
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.22
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 6.8%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹0.31 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 8.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 11.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.20
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 1,65,871
Veerhealth Care share news and announcements
544 announcements, routine notices left out, newest first. Page 5 of 11.
Aug 2023
4 Aug · Board meeting
Meeting on 14 Aug 2023: quarterly results, annual general meeting, bonus issue and increase in authorised capital
Jun 2023
13 Jun · Additional Details For Corporate Announcement Filed Dated 12Th June, 2023 Under Regulation 30 Of SEBI (LODR) Regulations, 2015
12 Jun · Announcement Under Regulation 30 (LODR) - Company Signed Contract To Supply 'WHIDENT' Range Of Toothpaste To North West African Cities
May 2023
15 May · Board meeting
Meeting on 22 May 2023: dividend and audited results
Apr 2023
19 Apr · Compliances - Certificate Under Regulation 40(9) Of SEBI (LODR) Regulations, 2015 For The Year Ended 31St March, 2023
17 Apr · Announcement Under Regulation 30 (LODR) - Permission Received For Disinfectant Manufacturing And In House Microbiology, Physical & Chemical Testing Laboratory At Our Vapi Factory
7 Apr · Compliance Certificate For The Period Ended March 31, 2023
Mar 2023
10 Mar · Board meeting
6 Mar · Board meeting
Meeting on 10 Mar 2023: preferential issue of shares
Feb 2023
28 Feb · Announcement Under Regulation 30 (LODR)-Order Of Condonation Of Delay
13 Feb · Board meeting
6 Feb · Board meeting
Meeting on 13 Feb 2023: quarterly results
Jan 2023
Dec 2022
19 Dec · Meeting
5 Dec · Board meeting
Nov 2022
28 Nov · Board meeting
Meeting on 5 Dec 2022: preferential issue of shares23 Nov · Results
14 Nov · Board meeting
Meeting on 23 Nov 2022: preferential issue of shares10 Nov · Board meeting
1 Nov · Board meeting
Meeting on 10 Nov 2022: quarterly results
Oct 2022
Sep 2022
Aug 2022
4 Aug · Board meeting
Meeting on 12 Aug 2022: annual general meeting and quarterly results
Jul 2022
May 2022